Immunos Therapeutics
Series BImmunos Therapeutics raised €68M in a Series B round in Jun 2022. The company is based in Schlieren, Switzerland. Investors in the round: BioMedPartners, Fiscus Financial, GIMV and 7 others. Data as of Nov 2026.
Amount raised
€68M
€68,118,584
Native amount
71,000,000 CHF
Stage
Series B
series b
Investors
10
Provenance & confidence
Low confidenceAmount
71,000,000 CHF
ECB-at-date → €68M · rate 1.0423 on 2022-06-07
High confidence
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
Investors in this round
10 namedBioMedPartnersFiscus FinancialGIMVGL CapitalLightspeed Venture PartnersMission BioCapitalPeak6 Strategic CapitalPfizer VenturesSamsara BiocapitalSchroder Adveq
Date
Jun 2022
Round type
series b
Amount (EUR)
€68M